ENMD-981693 Is an Orally-Active Kinase Inhibitor with Activity towards Human Hematologic Cancers In Vitro and In Vivo
Bray, Mark R., Fletcher, Graham C., Denny, Trisha A., Xu, John, Chen, Xiaoru, Burke, Patricia A., Franklin, Wanda, LaVallee, Theresa M., Minden, Mark D., Sidor, Carolyn F.
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article